Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Atea Pharmaceuticals Inc
About AVIR
Atea Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing oral antiviral therapies to address the unmet medical needs of patients with serious viral infections. The Company has built a proprietary nucleos(t)ide prodrug platform to develop product candidates to treat single-stranded ribonucleic acid (ssRNA) viruses, which are a prevalent cause of serious viral diseases. The Company’s lead program and focus is on the development of the regimen of bemnifosbuvir, a nucleotide analog polymerase inhibitor, and ruzasvir, an investigational, potent, small-molecule inhibitor of hepatitis C virus (HCV) non-structural protein 5A (NS5A), an essential protein for HCV replication. Bemnifosbuvir is an investigational, orally administered guanosine nucleotide double prodrug which targets the HCV non-structural protein 5B (NS5B) RNA-dependent RNA polymerase and inhibits HCV replication.
Find out what a historical investment in Atea Pharmaceuticals Inc would be worth today using our AVIR stock calculator.
Market Capitalisation
$335.31M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
203.36K
High today
$4.34
Low today
$4.20
Open price
$4.22
52-week high
$6.45
52-week low
$2.78
Ready to start your investing journey with Stake?
Open an accountHow do I buy AVIR shares in Australia?
Buying AVIR shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Atea Pharmaceuticals Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in AVIR
What is the ticker symbol of Atea Pharmaceuticals Inc?
The ticker symbol for Atea Pharmaceuticals Inc is AVIR.
How much is one share of AVIR?
One share of AVIR is valued at $4.24 as of 21 May 2026.
What is the market capitalisation of Atea Pharmaceuticals Inc AVIR?
As of 21 May 2026 Atea Pharmaceuticals Inc has a market cap of $335.31M.
What is the 52-week high for Atea Pharmaceuticals Inc stock?
The Atea Pharmaceuticals Inc 52-week high stock price is $6.45.
What is the 52-week low for Atea Pharmaceuticals Inc stock?
The Atea Pharmaceuticals Inc 52-week low stock price is $2.78.
Can I buy AVIR shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy AVIR shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in AVIR on Stake
- Buy AVIR from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of AVIR from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
AVIR related stocks